Edition:
India

Becton Dickinson and Co (BDX.N)

BDX.N on New York Stock Exchange

231.90USD
18 Sep 2020
Change (% chg)

$4.10 (+1.80%)
Prev Close
$227.80
Open
$226.16
Day's High
$233.91
Day's Low
$226.16
Volume
1,436,765
Avg. Vol
515,389
52-wk High
$286.67
52-wk Low
$197.75

Select another date:

Tue, Sep 15 2020

Becton Dickinson probes false-positive COVID-19 test results in U.S. nursing homes

Becton Dickinson said on Tuesday it is investigating reports from U.S. nursing homes that its rapid coronavirus testing equipment is producing false-positive results.

Becton Dickinson probes false-positive COVID-19 test results in U.S. nursing homes

Sept 15 Becton Dickinson said on Tuesday it is investigating reports from U.S. nursing homes that its rapid coronavirus testing equipment is producing false-positive results.

Becton on track to make one billion syringes to help COVID-19 vaccination

Becton Dickinson and Co said on Thursday it was on track to make 1 billion syringes in the next 12-18 months to meet demand for COVID-19 vaccination when approved, as the medical device maker reported quarterly revenue below estimates, sending its shares down nearly 9%.

UPDATE 3-Becton on track to make 1 bln syringes to help COVID-19 vaccination

Aug 6 Becton Dickinson and Co said on Thursday it was on track to make 1 billion syringes in the next 12-18 months to meet demand for COVID-19 vaccination when approved, as the medical device maker reported quarterly revenue below estimates, sending its shares down nearly 9%.

Becton Dickinson on track to produce one billion syringes in 12-18 months

Medical device maker Becton Dickinson and Co said on Thursday it would be able to produce 1 billion syringes in the next 12-18 months.

Becton Dickinson on track to produce 1 bln syringes in 12-18 months

Aug 6 Medical device maker Becton Dickinson and Co said on Thursday it would be able to produce 1 billion syringes in the next 12-18 months.

Becton Dickinson profit slumps nearly 37% on delayed surgeries

Aug 6 Medical technology company Becton Dickinson and Co on Thursday reported a 36.6% fall in quarterly profit, hurt by lower demand for its devices as people delayed non-urgent surgeries during the COVID-19 pandemic.

U.S. government agrees to buy Becton's COVID-19 testing devices

The U.S. government will buy Becton, Dickinson and Co's COVID-19 testing devices and kits, the company said on Wednesday, as it ramps up its testing for the virus that has been spreading at an alarming rate.

UPDATE 2-U.S. government agrees to buy Becton's COVID-19 testing devices

July 15 The U.S. government will buy Becton, Dickinson and Co's COVID-19 testing devices and kits, the company said on Wednesday, as it ramps up its testing for the virus that has been spreading at an alarming rate.

U.S. govt to invest $42 million in Becton Dickinson to ramp up vaccination efforts

Becton Dickinson and Co said on Wednesday the U.S. government will invest $42 million to expand the medical technology company's manufacturing capacity for syringes and needles to support vaccination efforts against COVID-19.

Select another date: